Company: RNST
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0000715072-25-000054
Chunk: 151

Company: RENASANT CORP
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 151
---
)— (53,727)Common stock issued in public offering7,187,500 35,938 — 181,062 — — 217,000 Issuance of common stock for stock-based compensation awards235,983 — 8,053 (11,379)— — (3,326)Stock-based compensation expense— — — 13,883 — — 13,883 Balance at December 31, 202463,565,690 $332,421 $(97,196)$1,491,847 $1,093,854 $(142,608)$2,678,318 

See Notes to Consolidated Financial Statements.

71

Renasant Corporation and Subsidiaries

Consolidated Statements of Cash Flows 

(In Thousands, Except Share Data) Year Ended December 31, 202420232022Operating activitiesNet income$195,457 $144,678 $166,068 Adjustments to reconcile net income to net cash provided by operating activities:Provision for credit losses9,273 15,593 23,871 Depreciation, amortization and accretion32,284 35,231 42,744 Deferred income tax expense (benefit)4,649 (5,005)2,280 Impairment losses on securities— 19,352 — Proceeds from sale of mortgage servicing rights23,011 — 18,525 Gain on sale of mortgage servicing rights(3,472)(547)(2,960)Gain on sale of insurance agency(53,349)— — Funding of mortgage loans held for sale(1,400,467)(1,330,912)(1,679,356)Proceeds from sales of mortgage loans held for sale1,347,659 1,277,363 2,043,360 Gains on sales of mortgage loans held for sale(16,611)(14,573)(15,803)Losses on sales of securities— 22,438 — Gain on debt extinguishment(56)(620)— Losses (gains) on sales of premises and equipment33 (173)(239)Stock-based compensation13,883 13,716 11,505 Increase in other assets(15,014)(51,986)(29,671)(Decrease) increase in other liabilities(7,854)